MARKET WIRE NEWS

Expected earnings - Raphael Pharmaceutical Inc Com (New)

Source: US Earnings Reports
Raphael Pharmaceutical Inc Com (New) (RAPH) is expected to report for Q2 2025
Raphael Pharmaceutical Inc Com (New)

NASDAQ: RAPH

RAPH Trading

286.74% G/L:

$1.40 Last:

200 Volume:

$1.3592 Open:

mwn-alerts Ad 300

RAPH Latest News

RAPH Stock Data

$27,476,985
9,028,152
8.29%
N/A
Pharmaceuticals
Healthcare
IL
Tel Aviv-Jaffa

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App